This study is currently not recruiting participants.

An Open-label (Part One) and a Randomized Double-Blind Placebo-Controlled (Part Two) Study of the Pharmacokinetics Safety Efficacy and Tolerability of Memantine in Pediatric Patients with Autism

Investigation of DNA Samples for Autism Spectrum Disorder Treatment

Not Recruiting
6 years - 12 years
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to collect DNA samples to help find a treatment for Autism.

Detailed description of study

The purpose of this study is to collect DNA samples to help find a treatment for Autism.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Autism
  • Age: 6 years - 12 years
  • Gender: All

The purpose of this study is to investigate the collection of DNA samples to better understand Autism. Autism is a developmental disorder that affects communication and behavior. By studying DNA, researchers aim to gain insights into potential treatments for Autism.

Participants in this study will provide DNA samples. DNA, or deoxyribonucleic acid, is the material in our cells that carries genetic information. The collection of these samples will help researchers analyze genetic factors related to Autism.

  • Who can participate: Individuals diagnosed with Autism and their families may be eligible to participate. Age criteria will be specified for eligible participants.
  • Study details: Participants will be required to provide a DNA sample, which is typically collected via a saliva or blood sample. No placebo is involved in this study.
Updated on 19 Feb 2024. Study ID: 1011003114

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team